Immunogenicity of biologics in inflammatory bowel disease

Crohn’s disease and ulcerative colitis are chronic inflammatory disorders of the gastrointestinal tract. Treatment options include biologic therapies; however, a proportion of patients lose response to biologics, partly due to the formation of anti-drug antibodies (ADAbs). Concomitant immunosuppress...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Therap Adv Gastroenterol
Asıl Yazarlar: Vermeire, Séverine, Gils, Ann, Accossato, Paola, Lula, Sadiq, Marren, Amy
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: SAGE Publications 2018
Konular:
Systematic Review
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5784568/
https://ncbi.nlm.nih.gov/pubmed/29383030
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1756283X17750355
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller